|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 247.11 USD | -2.30% |
|
-4.32% | +2.59% |
| 03-05 | Resmed Insider Sold Shares Worth $520,440, According to a Recent SEC Filing | MT |
| 03-04 | ASX Biggest Gainers | MT |
| Capitalization | 35.84B 30.78B 27.82B 26.64B 48.65B 3,292B 50.18B 328B 131B 1,578B 135B 132B 5,650B | P/E ratio 2026 * |
23.3x | P/E ratio 2027 * | 20.9x |
|---|---|---|---|---|---|
| Enterprise value | 34.77B 29.86B 26.99B 25.84B 47.2B 3,194B 48.69B 318B 127B 1,531B 131B 128B 5,482B | EV / Sales 2026 * |
6.16x | EV / Sales 2027 * | 5.6x |
| Free-Float |
76.64% | Yield 2026 * |
0.98% | Yield 2027 * | 1.09% |
Last Transcript: ResMed, Inc.
| 1 day | -2.30% | ||
| 1 week | -4.32% | ||
| Current month | -3.57% | ||
| 1 month | -6.23% | ||
| 3 months | -1.75% | ||
| 6 months | -8.64% | ||
| Current year | +2.59% |
| 1 week | 246.17 |  | 258.2 |
| 1 month | 245.65 | | 262.17 |
| Current year | 240 | | 277.67 |
| 1 year | 199.92 | | 293.81 |
| 3 years | 132.24 | | 293.81 |
| 5 years | 132.24 | | 301.34 |
| 10 years | 55.13 | | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 53 | 28/02/2013 |
Brett Sandercock
DFI | Director of Finance/CFO | 59 | 31/12/2005 |
Jim Ellis
CMP | Compliance Officer | - | 31/12/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 78 | 31/12/2004 |
Mick Farrell
CHM | Chairman | 53 | 24/01/2023 |
Peter Farrell
CHM | Chairman | 83 | 31/05/1989 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -1.50% | 1.09% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.30% | -4.32% | +4.43% | +20.04% | 36.68B | |
| -1.94% | -1.58% | -5.07% | -8.04% | 189B | |
| -1.56% | -2.33% | +0.67% | +116.17% | 175B | |
| -1.80% | -4.31% | -4.88% | -18.57% | 141B | |
| -2.70% | -5.27% | -25.68% | +50.52% | 107B | |
| -0.05% | -0.22% | -23.03% | -20.99% | 51.74B | |
| +1.80% | +0.59% | +25.17% | +15.39% | 48.94B | |
| -3.83% | -6.91% | -14.80% | -2.99% | 34.47B | |
| -1.04% | -3.03% | -5.31% | -14.95% | 32.96B | |
| +0.87% | -0.03% | -26.63% | -41.78% | 31.31B | |
| Average | -1.26% | -2.48% | -7.51% | +9.48% | 84.81B | |
| Weighted average by Cap. | -1.56% | -2.68% | -6.58% | +23.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.64B 4.85B 4.38B 4.19B 7.66B 518B 7.9B 51.6B 20.66B 249B 21.18B 20.73B 890B | 6.07B 5.21B 4.71B 4.51B 8.24B 557B 8.49B 55.46B 22.21B 267B 22.77B 22.29B 957B |
| Net income | 1.54B 1.32B 1.2B 1.15B 2.09B 142B 2.16B 14.1B 5.65B 67.91B 5.79B 5.67B 243B | 1.73B 1.48B 1.34B 1.28B 2.34B 158B 2.42B 15.77B 6.32B 75.97B 6.48B 6.34B 272B |
| Net Debt | -1.07B -915M -827M -792M -1.45B -97.89B -1.49B -9.74B -3.9B -46.93B -4B -3.92B -168B | -1.87B -1.61B -1.45B -1.39B -2.54B -172B -2.62B -17.12B -6.86B -82.48B -7.03B -6.88B -295B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/03/26 | 247.11 $ | -2.30% | 930,698 |
| 09/03/26 | 252.93 $ | +0.02% | 1,049,213 |
| 06/03/26 | 252.87 $ | -0.96% | 920,796 |
| 05/03/26 | 255.32 $ | -1.44% | 865,475 |
| 04/03/26 | 259.05 $ | +0.30% | 664,356 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RMD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition